Stay updated on Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry for v3.6.3, indicating a software update to the ClinicalTrials.gov page. This change updates the version label in the history and does not affect the study data or eligibility details.
    Difference
    0.1%
    Check dated 2026-07-05T14:20:25.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A new revision entry v3.6.2 is added to the study's record history, and the previous revision v3.6.0 is removed from the current history list.
    Difference
    0.1%
    Check dated 2026-06-28T08:30:21.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The study's recruitment status changed to 'No longer looking for participants', signaling that enrollment has ended. The record history now includes a new revision tag v3.6.0 and shows the removal of the previous revision tag v3.5.5.
    Difference
    0.5%
    Check dated 2026-06-13T17:52:04.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry (v3.5.5) appears in the study record history, replacing the previous revision (v3.5.4). This indicates a metadata update to the page without altering the core study data or descriptions.
    Difference
    0.1%
    Check dated 2026-06-06T14:08:38.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The record history now shows a new revision (v3.5.4) for the study record, reflecting an update to the page.
    Difference
    0.1%
    Check dated 2026-05-15T23:19:31.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s page footer revision/version indicator was updated from v3.5.2 to v3.5.3, indicating a system release rather than a change to the displayed study record.
    Difference
    0.1%
    Check dated 2026-04-24T17:10:00.000Z thumbnail image

Stay in the know with updates to Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neoadjuvant Pyrotinib in HER-2+ Breast Cancer Clinical Trial page.